The hyperdeliverability of the latest evolution of drug-eluting stents should not cause any steps to be omitted during percutaneous coronary intervention-论文-万方医学网

首页> > The hyperdeliverability of the latest evolution of drug-eluting stents should not cause any steps to be omitted during percutaneous coronary intervention

The hyperdeliverability of the latest evolution of drug-eluting stents should not cause any steps to be omitted during percutaneous coronary intervention

导出原文传递

翻译打印收藏纠错

第一作者： Barone-Rochette, Gilles

作者： Barone-Rochette, Gilles ^[1]

作者单位： INSERM,Univ Grenoble Alpes ^[1]

关键词 Ultrathin-strut drug-eluting stent Hyperdeliverability Optimal implantation techniques BARE-METAL STENTS DURABLE POLYMER THROMBOSIS INSIGHTS OUTCOMES RISK IMPLANTATION

发布时间 2022-06-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

The hyperdeliverability of the latest evolution of drug-eluting stents should not cause any steps to be omitted during percutaneous coronary intervention

相似文献

同项目论文

相关期刊

检索历史 清除

The hyperdeliverability of the latest evolution of drug-eluting stents should not cause any steps to be omitted during percutaneous coronary intervention

相似文献

同项目论文

相关期刊

检索历史清除